Matthew B. Murphy - General Counsel at Nautilus Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Issuer Symbol
NAUT on Nasdaq
All Insider Reports
All Insider Reports

Matthew B. Murphy - trading volume in the past year for Nautilus Biotechnology, Inc.

Holdings reported by Matthew B. Murphy for Nautilus Biotechnology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 74,140 $47,664 $0.6429 04 Sep 2025 Indirect
Common Stock 1,250 $1,000 $0.8000 04 Sep 2025 Direct
Stock Option (Right to Buy) 160,000 02 Mar 2026 Direct Common Stock

Transactions reported by Matthew B. Murphy for Nautilus Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.